DAVITA INC. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2017-06-15: Study NCT02358967; Company role Collaborator; Phase Not applicable; Status Completed.
- 2015-10: Study NCT02360748; Company role Collaborator; Phase Not applicable; Status Completed.
- 2010-07: Study NCT01116947; Company role Collaborator; Phase Not applicable; Status Completed.
- 2009-02: Study NCT00785629; Company role Collaborator; Phase Not applicable; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2017-06-15 | NCT02358967 Palm Tocotrienols in Chronic Hemodialysis (USA) | Collaborator Lead: Wayne State University | Not applicable | Completed | End Stage Renal Disease; Chronic Kidney Disease | 280 | 2020-08-31 |
| 2015-10 | NCT02360748 A Plant Based High Protein Diet to Improve Nutritional Outcomes in Peritoneal Dialysis Patients | Collaborator Lead: Ochsner Health System | Not applicable | Completed | End-Stage Renal Disease; Malnutrition | 8 | 2017-09-15 |
| 2010-07 | NCT01116947 Fosrenol for Enhancing Dietary Protein Intake in Hypoalbuminemic Dialysis Patients (FrEDI) Study | Collaborator Lead: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Not applicable | Completed | End-Stage Renal Disease | 108 | 2012-02 |
| 2009-02 | NCT00785629 A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD | Collaborator Lead: Denver Nephrologists, P.C. | Not applicable | Completed Results posted | Chronic Kidney Disease | 148 | 2011-07 |
| 2008-11 | NCT00692419 Pain, Sexual Dysfunction, and Depression in Hemodialysis Patients | Collaborator Lead: US Department of Veterans Affairs | Not applicable | Completed Results posted | End Stage Renal Disease; Sexual Dysfunction, Physiological; Pain; Depression | 315 | 2012-01 |
| 2008-02 | NCT00561093 Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients | Collaborator Lead: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Phase 3 | Completed | Hypoalbuminemia; Protein-energy Malnutrition; Inflammation; Oxidative Stress; Chronic Kidney Disease (CKD) Hemodialysis | 93 | 2011-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |